Low-molecular weight heparin prophylaxis in acutely ill medical inpatients prevented 48% of symptomatic pulmonary embolism and 51% of asymptomatic deep vein thrombosis.
Meta-Analysis
Does low-molecular weight heparin prophylaxis reduce the risk of venous thromboembolism in acutely ill medical inpatients?
LMWH prophylaxis in acutely ill medical inpatients reduces the risk of symptomatic PE and asymptomatic DVT by approximately half, though with a nonsignificant trend toward increased bleeding.
Estimación del efecto: 48% reduction in symptomatic PE, 51% reduction in asymptomatic DVT
OBJECTIVES: Venous thromboembolism (VTE) is a potentially serious complication of hospitalization and immobilization. The use of anticoagulant prophylaxis in acutely ill medical inpatients is still under debate. New data including a recent meta-analysis have recently been published. We aim at studying the efficacy and safety of anticoagulant prophylaxis in acutely ill medical inpatients, and demonstrate differences between meta-analyses due to different data extraction from the heterogeneous studies included. SUBJECTS: The Cochrane Library, MEDLINE and EMBASE were searched from 1980 to present. Manual searches were performed regarding abstracts from major meetings. Seven blinded randomized controlled clinical trials assessing the prophylactic effect of heparin in acutely ill medical patients were identified and included in the meta-analysis. RESULTS: Low-molecular weight heparin (LMWH) prophylaxis prevented 48% of symptomatic pulmonary embolism (PE), 48% of symptomatic deep vein thrombosis (DVT) (not significant) and 51% of asymptomatic DVT. A nonsignificant trend towards higher bleeding risk during LMWH prophylaxis was found. Death was not significantly affected. We compared our data with a recent meta-analysis with different study selection and data extraction and found similar results. CONCLUSIONS: As DVT and PE are manifestations of the same illness, VTE, one can argue that anticoagulant prophylaxis prevents approximately half of the expected events. Most medical inpatients have short hospital stays, and a low risk of VTE. The important task for the clinician is to identify patients with a sufficiently high risk of symptomatic VTE to warrant LMWH prophylaxis. Despite differences in study selection and data extraction, our study shows results similar to a recent meta-analysis.
Själander et al. (Fri,) conducted a meta-analysis in Acutely ill medical inpatients at risk of venous thromboembolism. Low-molecular weight heparin (LMWH) prophylaxis was evaluated on Symptomatic pulmonary embolism (PE), symptomatic deep vein thrombosis (DVT), and asymptomatic DVT (48% reduction in symptomatic PE, 51% reduction in asymptomatic DVT). Low-molecular weight heparin prophylaxis in acutely ill medical inpatients prevented 48% of symptomatic pulmonary embolism and 51% of asymptomatic deep vein thrombosis.